Cite
HARVARD Citation
He, S. et al. (n.d.). A phase II FOLFOX-4 regimen as second-line treatment in advanced biliary tract cancer refractory to gemcitabine/cisplatin. Journal of chemotherapy. pp. 243-247. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
He, S. et al. (n.d.). A phase II FOLFOX-4 regimen as second-line treatment in advanced biliary tract cancer refractory to gemcitabine/cisplatin. Journal of chemotherapy. pp. 243-247. [Online].